echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > JCI insight: how does fibrosis develop in the lungs?

    JCI insight: how does fibrosis develop in the lungs?

    • Last Update: 2019-11-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    November 20, 2019 / biourn / -- recently, a study led by Yale University has increased our understanding of the process of pulmonary fibrosis (IPF), providing researchers with a roadmap to explore new therapeutic targets for the disease The study, led by Naftali Kaminski, Ph.D., of Yale University School of medicine and John E McDonough, Professor of internal medicine at Brigham inger University (lecturer and researcher at the lab), was published in the recent journal JCI In this study, researchers examined areas of lung differential infection obtained from individuals with IPF and found that specific genes had changed in what looked like normal lungs Then they tracked how these genes increased or decreased as the disease progressed Kaminski said the paper is unique in that it provides the first computational model of IPF progress, along with an interactive website to explore the model Kaminski believes that extensive access to data will accelerate the study of new therapies in IPF (image source: www Pixabay Com) although Kaminski points out that scientists at Yale University and elsewhere have made "substantial scientific progress" in IPF in recent years, there are few available treatments IPF is a chronic disease The main symptom is the deterioration of pulmonary fibrosis, which eventually leads to failure of normal work It affects about 200000 people in the United States, with about 30000 new cases a year Within three to five years of diagnosis, 50% of IPF patients will die, but the cause is not clear Two FDA approved drugs for the treatment of IPF can slow the progress of the disease, but can not be reversed Drug testing for IPF is still ongoing, he said, adding that the latest study should provide researchers with the opportunity to identify new potential drug targets How fiber progress in the human lung original source: John E McDonough et al., transcription regulatory model of fiber progress in the human lung JCI insight, 2019; 4 (22) doi: 10.1172/jci.insight.131597
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.